Skip to main content
UCL Logo Navigate back to homepage

Main navigation

  • Home
  • Study

    Study

    • Study at UCL
    • Prospective students
    • Current students
    • Accommodation
    • Careers
    • Doctoral School
    • Immigration and visas
    • Student finances
    • Support and wellbeing
  • Research

    Research

    • Research at UCL
    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage

    Engage

    • Engage with UCL
    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Policy and political engagement
    • Schools and priority groups
    • Give to UCL
  • About

    About

    • About UCL
    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
    • UCL's Bicentenary
  • UCL Logo Active parent page: Faculty of Medical Sciences
    • Study
    • Research
    • Divisions and Institutes
    • Events
    • About
    • Active parent page: News
    • Contacts

Six UCL scientists elected Fellows of the Royal Society

Six scientists from the UCL community have been elected as Fellows of the Royal Society in recognition of their outstanding contributions to research and innovation that benefit humanity.

10 May 2018

UCL Royal Society Fellows 2018

Breadcrumb trail

  • Faculty of Medical Sciences

Faculty menu

  • Study
  • Research
  • Divisions and Institutes
  • Events
  • About
  • Current page: News
  • Contacts

Breadcrumb trail

  • Faculty of Medical Sciences
  • Six UCL scientists elected Fellows of the Royal Society

Four UCL researchers – Professor Peter Dayan (UCL Gatsby Computational Neuroscience Unit), Professor Dimitri Kullmann (UCL Institute of Neurology), Professor Peter O’Hearn (UCL Computer Science) and Professor Charles Swanton (UCL Cancer Institute) – are among the 50 distinguished individuals recognised for their exceptional contributions to science, alongside two honorary staff members, Dr Demis Hassabis (UCL Gatsby Computational Neuroscience Unit) and Dr Vassilis Pachnis (UCL Biosciences). 

Professor Peter Dayan is recognised internationally as a leader in the rapidly developing field of computational neuroscience, applying methods from machine learning and artificial intelligence to understand neural function, with a particular emphasis on representation and learning. He won the 2017 Brain Prize for his analysis of how the brain recognises and processes reward.

Professor Dimitri Kullmann works on basic neuroscience and its application to clinical neurology. He has played a key role in important discoveries about the fundamental mechanisms of how neurotransmitters pass information from one neuron to another, the computational properties of small neuronal circuits, and how those processes can differ in epilepsy and other neurological disorders. He is a consultant neurologist at the National Hospital for Neurology and Neurosurgery and current Editor of Brain.

Professor Peter O’Hearn has made major contributions to the science and engineering of methods for ensuring program correctness. His impressive portfolio of research ranges from abstract topics such as mathematical models to the logics of programs, automated analysis of industrial software in the millions of lines of code and its application to industry. He is based at UCL and Facebook following the 2013 acquisition of his startup, Monoidics, and now joins an esteemed network of just 31 computer scientists at the Royal Society. 

Professor Charles Swanton leads a lab at the Francis Crick Institute, is Co-Director of the CRUK UCL Cancer Institute Lung Cancer Centre of Excellence and a consultant thoracic medical oncologist at UCLH. He researches how tumours evolve into cancer cells that have different genetic mistakes, contributing to the drug resistant and incurable nature of metastatic cancer. His work has led to valuable insights into molecular mechanisms driving cancer branched evolution.

After completing his PhD in cognitive neuroscience at UCL, Dr Demis Hassabis went on to co-found DeepMind technologies, a London-based machine learning AI startup that was acquired by Google in 2014, while continuing to collaborate with and support UCL. His fellowship recognises his pioneering work merging cognitive neuroscience and machine learning to produce breakthroughs in deep learning that helped master the game of Go with AlphaGo.

Dr Vassilis Pachnis is a group leader at the Francis Crick Institute and honorary professor at UCL. His research focuses on the genetic and molecular underpinnings of the development, assembly and maintenance of two sets of neural circuits: those that are intrinsic to the gut wall and regulate gastrointestinal activity and those that provide inhibition in the cerebral cortex of the brain. By understanding these processes, his team hopes to gain insight into causes of neurodevelopmental diseases.

The Fellowship of the Royal Society is made up of the most eminent scientists, engineers and technologists from or living and working in the UK and the Commonwealth.

Professor Michael Arthur, UCL’s President & Provost, said: “The UCL community takes great pride in our six new Fellows of the Royal Society, as it is an immense honour and I am delighted that their outstanding contribution to science has been recognised in this way. I offer my warmest congratulations to Peter Dayan, Dimitri Kullmann, Peter O’Hearn, Charles Swanton, Demis Hassabis and Vassilis Pachnis, who all exemplify UCL’s global impact across a wide range of academic fields.”

Links

  • Royal Society announcement
  • Professor Peter Dayan’s academic profile
  • Professor Dimitri Kullmann’s academic profile
  • Professor Peter O’Hearn’s academic profile
  • Professor Charles Swanton’s academic profile
  • DeepMind and Dr Demis Hassabis
  • Dr Vassilis Pachnis’s profile

Image

  • Clockwise from top left: Peter Dayan, Dimitri Kullmann, Peter O’Hearn, Vassilis Pachnis, Demis Hassabis, and Charles Swanton

Highlights in Medical Sciences

Groundbreaking bowel cancer trial follow-up shows zero relapses
close up view of a mans arm while having an IV immunoglobulin infusion at hospital

Research

Groundbreaking bowel cancer trial follow-up shows zero relapses

Patients with a specific bowel cancer who were given short-course immunotherapy before surgery, instead of post-op chemotherapy, remained cancer-free after nearly three years of follow-up.

Drug to treat aggressive leukaemia approved for use in adults
Fluorescence microscopy image of immune cells, showing blue-stained nuclei surrounded by green cell membranes with red marker signals indicating specific proteins or activity within the cells.

Research

Drug to treat aggressive leukaemia approved for use in adults

Adult patients with aggressive leukaemia will soon be able to receive a breakthrough immunotherapy, developed by UCL researchers, on the NHS after approval by NICE.

Millions could benefit from faster prostate cancer scan
healthy prostate scan

Research

Millions could benefit from faster prostate cancer scan

Results of the PRIME trial involving UCL Medical Sciences researchers have found that a quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources
UCL Logo

University College London

Gower Street, London, WC1E 6BT

Telephone: +44 (0) 20 7679 2000

UCL social media menu

  • Link to Instagram
  • Link to LinkedIn
  • Link to Youtube
  • Link to TikTok
  • Link to Facebook
  • Link to Bluesky
  • Link to Threads
  • Link to Soundcloud
Here, it can happen.
Back to top

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in

© 2026 UCL